Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:17:34 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:QGEN from 2023-05-07 to 2024-05-06 - 43 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 16:05U:QGENNews ReleaseQIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
2024-04-29 16:05U:QGENNews ReleaseQIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
2024-04-24 16:05U:QGENNews ReleaseQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
2024-04-09 09:49U:QGENNews ReleaseQIAGEN N.V. to release results for Q1 2024 and hold webcast
2024-04-03 16:05U:QGENNews ReleaseQIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
2024-03-25 16:05U:QGENNews ReleaseQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
2024-03-18 16:05U:QGENNews ReleaseQIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
2024-03-11 06:00U:QGENNews ReleaseQIAGEN announces Form 20-F annual report filing for 2023 results
2024-02-27 17:45U:QGENNews ReleaseQIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
2024-02-27 16:05U:QGENNews ReleaseQIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
2024-02-15 16:05U:QGENNews ReleaseQIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
2024-02-06 16:05U:QGENNews ReleaseQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
2024-01-25 10:00U:QGENNews ReleaseQIAGEN announces partnership with Penn State University to advance microbiome sciences
2024-01-18 16:05U:QGENNews ReleaseQIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million
2024-01-11 07:54U:QGENNews ReleaseQIAGEN N.V. to release results for Q4 2023 and hold webcast
2024-01-08 02:00U:QGENNews ReleaseQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
2024-01-07 13:07U:QGENNews ReleaseQIAGEN announces plans to return approximately $300 million to shareholders
2024-01-04 16:05U:QGENNews ReleaseQIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business
2024-01-03 02:00U:QGENNews ReleaseQIAGEN expands business in Middle East with new regional headquarters and major projects
2023-11-30 16:05U:QGENNews ReleaseDNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy
2023-11-15 16:05U:QGENNews ReleaseQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation
2023-11-09 16:05U:QGENNews ReleaseQIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers
2023-11-06 16:05U:QGENNews ReleaseQIAGEN launches complete Sample to Insight workflow for microbiome research
2023-11-02 08:00U:QGENNews ReleaseQIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System
2023-11-02 08:00U:QGENNews ReleaseQIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System
2023-10-30 16:05U:QGENNews ReleaseQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CER
2023-10-26 08:00U:QGENNews ReleaseQIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
2023-10-26 08:00U:QGENNews ReleaseQIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
2023-10-09 11:15U:QGENNews ReleaseQIAGEN N.V. to release results for Q3 2023 and hold webcast
2023-10-04 16:05U:QGENNews ReleaseQIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus
2023-09-28 16:05U:QGENNews ReleaseQIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness
2023-09-27 16:05U:QGENNews ReleaseQIAGEN reports progress toward achieving Environmental, Social and Governance goals in 2022 Sustainability Report
2023-09-25 16:05U:QGENNews ReleaseQIAGEN enhances QIAwave portfolio with new eco-friendlier nucleic acid extraction kits
2023-08-08 16:05U:QGENNews ReleaseQIAGEN delivers ahead of outlook for Q2 2023 with 9% CER sales growth in non-COVID products and updates 2023 full-year outlook
2023-08-07 16:05U:QGENNews ReleaseQIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines ¢ € ™ AYVAKIT ‚ ® (avapritinib) in gastrointestinal stromal tumors
2023-07-26 16:15U:QGENNews ReleaseBio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
2023-07-26 16:15U:QGENNews ReleaseBio-Rad and QIAGEN announce patent settlement and cross-licensing agreement
2023-07-24 07:41U:QGENNews ReleaseQIAGEN N.V. to release results for Q2 2023 and hold webcast
2023-07-18 16:05U:QGENNews ReleaseQIAGEN expands range of digital PCR kits and services for the biopharma industry
2023-06-20 16:05U:QGENNews ReleaseFBI approves QIAGEN ¢ € ™s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
2023-06-16 07:37U:QGENNews ReleaseQIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes
2023-06-15 16:05U:QGENNews ReleaseQIAGEN ¢ € ™s QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening
2023-06-13 16:05U:QGENNews ReleaseDanish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing